Why CRISPR Therapeutics AG Stock Edged Higher in October – Motley Fool
|
Why CRISPR Therapeutics AG Stock Edged Higher in October
Motley Fool After a turbulent September, genome-editing company CRISPR Therapeutics AG (NASDAQ:CRSP) saw its shares gain 8% last month, according to S&P Global Market Intelligence. Although the company did announce the promotion of President Samarth … |
